Graham Mc Clorey

I completed my PhD program at the University of Western Australia focusing on the development of antisense oligonucleotides to modulate splicing in disease models of Duchenne muscular dystrophy, in particular in canine and human cellular models. I have been a Postdoctoral Research Scientist at in the University of Oxford in the field of pre-clinical translational research for the past 11 years where my focus has been predominantly on development of antisense oligonucleotide therapeutics for neuromuscular diseases, in particular for Duchenne muscular dystrophy (DMD). In my current role, I am lead scientist and Project Manager in the group for a number of collaborative programs with pharmaceutical partners focusing on pre-clinical development of novel therapeutic drugs for DMD.